Trial Profile
A Phase Ib Pilot Multiple Dose, Randomized-Withdrawal, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Pharmacokinetics of Topically Applied 40% Lidocaine Gel Compared With Placebo in Subjects With Acute Herpes Zoster Pain
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 27 Apr 2021
Price :
$35
*
At a glance
- Drugs Lidocaine (Primary)
- Indications Pain
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Centrexion Therapeutics
- 22 Feb 2016 New trial record